 |
JOURNAL TOOLS |
| Publishing options |
| eTOC |
| To subscribe |
| Submit an article |
| Recommend to your librarian |
ARTICLE TOOLS |
| Reprints |
| Permissions |
| Share |
YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
SPECIAL ARTICLES
Gazzetta Medica Italiana Archivio per le Scienze Mediche 2013 July-August;172(7-8):671-5
Copyright © 2013 EDIZIONI MINERVA MEDICA
language: Italian
Compliance to sublingual immunotherapy
Landi M. 1, Gani F. 2, Marchino F. 2
1 Pediatria di Gruppo, Asl TO1, Torino, Italia; 2 Servizio di Allergologia Respiratoria, Clinica di Malattie dell’Apparato Respiratorio, Azienda Ospedaliera Universitaria San Luigi, Orbassano, Torino, Italia
Currently, adherence is one of the major concerns about sublingual immunotherapy (SLIT) managed by the patient at home. The problem is the same with other drugs (inhaled corticosteroids, antihistamines) and it is well known that the low adherence is a major cause of failure or poor efficacy of treatments. In the case of immunotherapy, it could be expected that SLIT is inferior to SCIT in terms of adherence, although the experimental data show that the adherence to SCIT is far from being satisfactory, mainly because of inconvenience or side effects. Measuring the adherence is not easy to do but is necessary.